AAAAAA
Results:
1-14
|
Results: 14
Authors:
Dagher, A
Bleicher, C
Aston, JAD
Gunn, RN
Clarke, PBS
Cumming, P
Citation: A. Dagher et al., Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers, SYNAPSE, 42(1), 2001, pp. 48-53
Authors:
Boye, SM
Grant, RJ
Clarke, PBS
Citation: Sm. Boye et al., Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats, NEUROPHARM, 40(6), 2001, pp. 792-805
Authors:
Reuben, M
Clarke, PBS
Citation: M. Reuben et Pbs. Clarke, Nicotine-evoked [H-3]5-hydroxytryptamine release from rat striatal synaptosomes, NEUROPHARM, 39(2), 2000, pp. 290-299
Authors:
Fraser, GL
Holmgren, J
Clarke, PBS
Wahlestedt, C
Citation: Gl. Fraser et al., Antisense inhibition of delta-opioid receptor gene function in vivo by peptide nucleic acids, MOLEC PHARM, 57(4), 2000, pp. 725-731
Authors:
Fraser, GL
Parenteau, H
Tu, TM
Ducharme, J
Perkins, MN
Clarke, PBS
Citation: Gl. Fraser et al., The effects of delta agonists on locomotor activity in habituated and non-habituated rats, LIFE SCI, 67(8), 2000, pp. 913-922
Authors:
Fraser, GL
Pradhan, AA
Clarke, PBS
Wahlestedt, C
Citation: Gl. Fraser et al., Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) ispharmacologically distinct from that to other delta-agonists in the rat, J PHARM EXP, 295(3), 2000, pp. 1135-1141
Authors:
Reuben, M
Boye, S
Clarke, PBS
Citation: M. Reuben et al., Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically, EUR J PHARM, 393(1-3), 2000, pp. 39-49
Authors:
Boye, SM
Clarke, PBS
Citation: Sm. Boye et Pbs. Clarke, Enhancement of haloperidol-induced catalepsy by nicotine: an investigationof possible mechanisms, CAN J PHYSL, 78(11), 2000, pp. 882-891
Authors:
Fraser, GL
Gaudreau, GA
Clarke, PBS
Menard, DP
Perkins, MN
Citation: Gl. Fraser et al., Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation, BR J PHARM, 129(8), 2000, pp. 1668-1672
Authors:
Marenco, T
Bernstein, S
Cumming, P
Clarke, PBS
Citation: T. Marenco et al., Effects of nicotine and chlorisondamine on cerebral glucose utilization inimmobilized and freely-moving rats, BR J PHARM, 129(1), 2000, pp. 147-155
Authors:
Gioanni, Y
Rougeot, C
Clarke, PBS
Lepouse, C
Thierry, AM
Vidal, C
Citation: Y. Gioanni et al., Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission, EUR J NEURO, 11(1), 1999, pp. 18-30
Authors:
Fraser, GL
Labarre, M
Godbout, C
Butterworth, J
Clarke, PBS
Payza, K
Schmidt, R
Citation: Gl. Fraser et al., Characterization of [I-125]AR-M100613, a high-affinity radioligand for delta opioid receptors, PEPTIDES, 20(11), 1999, pp. 1327-1335
Authors:
Lukas, RJ
Changeux, JP
Le Novere, N
Albuquerque, EX
Balfour, DJK
Berg, DK
Bertrand, D
Chiappinelli, VA
Clarke, PBS
Collins, AC
Dani, JA
Grady, SR
Kellar, KJ
Lindstrom, JM
Marks, MJ
Quik, M
Taylor, PW
Wonnacott, S
Citation: Rj. Lukas et al., International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits, PHARM REV, 51(2), 1999, pp. 397-401
Authors:
Louis, M
Clarke, PBS
Citation: M. Louis et Pbs. Clarke, Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats, NEUROPHARM, 37(12), 1998, pp. 1503-1513
Risultati:
1-14
|